APR 27, 2017 02:41 PM PDT

Cheap Drug Drastically Cuts Maternal Deaths


A drug created created in the 1960s is now credited as a powerful tool that can save thousands of women from bleeding to death during and after childbirth.

In an international trial that included 20,000 women in 21 countries, researchers found that the drug called tranexamic acid drastically reduced the risks of women dying from postpartum hemorrhage. The condition of heavy bleeding after childbirth affects 100,000 women every year, making it the biggest cause of maternal death worldwide.

Tranexamic stops heavy bleeding by inhibiting the breakdown of blood clots. The drug slashed deaths related to hemorrhaging by 31 percent in women given the drug within three hours of childbirth.

In addition to its impressive effectiveness, researchers are also praising the drug’s cheap cost and minimal side effects. The drug is estimated to cost $3 in the UK, and even less in other countries, such as Pakistan.

"We found an inexpensive drug, given in a single shot, that reduces the risk of bleeding to death, and it should play a role in reducing maternal mortality around the world,” said Ian Roberts, one of the researchers.

"If you can save a life for approximately $3, then I believe that's worth doing," added Haleema Shakur, who directs clinical trials at the London School of Tropical Medicine and Hygiene.

Interestingly enough, the drug that’s now being lauded as a game-changer for preventing childbirth deaths was nearly all but forgotten since it was invented in the 1960s by a Japanese husband-wife pair, Shosuke and Utako Okamoto. According to Shakur, "It was Okamoto's dream to save women. But she couldn't convince doctors to test the drug on postpartum hemorrhaging."

Instead, the drug was marketed as treatment for heavy periods. If it wasn’t for the efforts of Shakur and colleagues, the drug may not have been resurrected for such a powerful purpose.

For Ukato Okamoto, it is never too late to save lives. "We wanted to work on something international, we wanted to discover new drugs to show our gratitude to humanity," she said of her and her husband’s goals decades ago. "We thought that would be wonderful."

Additional sources: BBC

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 08, 2018
Clinical & Molecular DX
JUN 08, 2018
Early Detection of Tooth Decay from Bacterial Invasion
We all get cavities, but have we ever thought much about the biology of the process? From the Akson Russian Science Communication Association, scientists i...
AUG 11, 2018
AUG 11, 2018
A Microbrewery can Help us Monitor Radiation Exposure
This wearable technology is very sensitive, and can be used by workers that are at risk of radiation exposure....
OCT 16, 2018
OCT 16, 2018
Simple Test Rapidly Diagnoses Antibiotic-resistant Infections
If we get a bacterial infection, doctors use antibiotics to treat it. But sometimes people are infected by pathogens that are resistant to drugs....
OCT 17, 2018
Cell & Molecular Biology
OCT 17, 2018
Saving Patients From Unnecessary Chemotherapy with a Blood Test
Often, cancer patients get chemotherapy after surgery to ensure that their cancer will not come back; for many it's not needed....
NOV 07, 2018
NOV 07, 2018
Herd Protection Against Measles
A 26-year-old leukemia patient dies from exposure to measles. Herd immunity can offer a level of protection for those with impaired immune systems....
NOV 21, 2018
NOV 21, 2018
What We Know About Kawasaki Disease
Kawasaki disease discovered by Dr. Tomisaku Kawasaki, a Japanese pediatrician, is a rare type of vasculitis, or inflammation of the blood vessels. It&rsquo...
Loading Comments...